Your browser doesn't support javascript.
loading
Metabolic Syndrome Features and Excess Weight Were Inversely Associated with Nut Consumption after 1-Year Follow-Up in the PREDIMED-Plus Study.
Julibert, Alicia; Del Mar Bibiloni, Maria; Gallardo-Alfaro, Laura; Abbate, Manuela; Martínez-González, Miguel Á; Salas-Salvadó, Jordi; Corella, Dolores; Fitó, Montse; Martínez, J Alfredo; Alonso-Gómez, Ángel M; Wärnberg, Julia; Vioque, Jesús; Romaguera, Dora; Lopez-Miranda, José; Estruch, Ramon; Tinahones, Francisco J; Lapetra, José; Serra-Majem, Lluís; Cano-Ibañez, Naomi; Martín-Sánchez, Vicente; Pintó, Xavier; Gaforio, José J; Matía-Martín, Pilar; Vidal, Josep; Vázquez, Clotilde; Daimiel, Lidia; Ros, Emilio; Sayon-Orea, Carmen; Becerra-Tomás, Nerea; Gimenez-Alba, Ignacio M; Castañer, Olga; Abete, Itziar; Tojal-Sierra, Lucas; Pérez-López, Jéssica; Notario-Barandiaran, Leyre; Colom, Antoni; Garcia-Rios, Antonio; Castro-Barquero, Sara; Bernal, Rosa; Santos-Lozano, José M; Fernández-Lázaro, Cesar I; Hernández-Alonso, Pablo; Saiz, Carmen; Zomeño, Maria D; Zulet, Maria A; Belló-Mora, Maria C; Basterra-Gortari, Javier; Canudas, Silvia; Goday, Albert; Tur, Josep A.
Afiliación
  • Julibert A; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Del Mar Bibiloni M; Research Group on Community Nutrition & Oxidative Stress, University of the Balearic Islands, Palma de Mallorca, Spain.
  • Gallardo-Alfaro L; Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain.
  • Abbate M; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Martínez-González MÁ; Research Group on Community Nutrition & Oxidative Stress, University of the Balearic Islands, Palma de Mallorca, Spain.
  • Salas-Salvadó J; Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain.
  • Corella D; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Fitó M; Research Group on Community Nutrition & Oxidative Stress, University of the Balearic Islands, Palma de Mallorca, Spain.
  • Martínez JA; Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain.
  • Alonso-Gómez ÁM; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Wärnberg J; Research Group on Community Nutrition & Oxidative Stress, University of the Balearic Islands, Palma de Mallorca, Spain.
  • Vioque J; Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain.
  • Romaguera D; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Lopez-Miranda J; Department of Preventive Medicine and Public Health, Navarra Health Research Institute (IDISNA), University of Navarra, Pamplona, Spain.
  • Estruch R; Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA, USA.
  • Tinahones FJ; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Lapetra J; Human Nutrition Unit, Biochemistry and Biotechnology Department, Pere Virgili Medical Research Institute (IISPV), Sant Joan University Hospital, University Rovira i Virgili, Reus, Spain.
  • Serra-Majem L; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Cano-Ibañez N; Department of Preventive Medicine, University of Valencia, Valencia, Spain.
  • Martín-Sánchez V; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Pintó X; Unit of Cardiovascular Risk and Nutrition, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
  • Gaforio JJ; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Matía-Martín P; Cardiometabolics Nutrition Program, Madrid Institute for Advanced Research (IMDEA) Food, Excellence International Campus, Autonomous University of Madrid and Higher Council of Scientific Research (CEI UAM + CSIC), Madrid, Spain.
  • Vidal J; Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, Pamplona, Spain.
  • Vázquez C; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Daimiel L; Department of Cardiology, OSI ARABA, University Hospital Araba, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain.
  • Ros E; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Sayon-Orea C; Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, Málaga, Spain.
  • Becerra-Tomás N; Alicante Health and Biomedical Research Institute and Miguel Hernández University (ISABIAL-UMH),Alicante, Spain.
  • Gimenez-Alba IM; CIBER Epidemiology and Public Health (CIBERESP), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Castañer O; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Abete I; Balearic Islands Health Research Institute (IdISBa), Palma de Mallorca, Spain.
  • Tojal-Sierra L; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Pérez-López J; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba, Spain.
  • Notario-Barandiaran L; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Colom A; Department of Internal Medicine, August Pi Sunyer Biomedical Research Institute (IDIBAPS), Clinic Hospital, University of Barcelona, Barcelona, Spain.
  • Garcia-Rios A; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Castro-Barquero S; Virgen de la Victoria Hospital, Department of Endocrinology, University of Málaga, Málaga, Spain.
  • Bernal R; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Santos-Lozano JM; Department of Family Medicine, Research Unit, Sevilla Primary Health Care District, Sevilla, Spain.
  • Fernández-Lázaro CI; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Hernández-Alonso P; Institute for Biomedical Research, University of Las Palmas de Gran Canaria, Las Palmas, Spain.
  • Saiz C; CIBER Epidemiology and Public Health (CIBERESP), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Zomeño MD; Department of Preventive Medicine, University of Granada, Granada, Spain.
  • Zulet MA; CIBER Diabetes and Metabolic Diseases (CIBERDEM), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Belló-Mora MC; Institute of Biomedicine (IBIOMED), University of León, Leon, Spain.
  • Basterra-Gortari J; CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Canudas S; Lipids and Vascular Risk Unit, Internal Medicine, Bellvitge University Hospital, Hospitalet de Llobregat, Barcelona, Spain.
  • Goday A; CIBER Epidemiology and Public Health (CIBERESP), Carlos III Health Institute (ISCIII), Madrid, Spain.
  • Tur JA; Department of Health Sciences, Center for Advanced Studies in Olive Grove and Olive Oils, University of Jaen, Jaen, Spain.
J Nutr ; 150(12): 3161-3170, 2020 12 10.
Article en En | MEDLINE | ID: mdl-33300039
BACKGROUND: High nut consumption has been previously associated with decreased prevalence of metabolic syndrome (MetS) regardless of race and dietary patterns. OBJECTIVES: The aim of this study was to assess whether changes in nut consumption over a 1-y follow-up are associated with changes in features of MetS in a middle-aged and older Spanish population at high cardiovascular disease risk. METHODS: This prospective 1-y follow-up cohort study, conducted in the framework of the PREvención con DIeta MEDiterránea (PREDIMED)-Plus randomized trial, included 5800 men and women (55-75 y old) with overweight/obesity [BMI (in kg/m2) ≥27 and <40] and MetS. Nut consumption (almonds, pistachios, walnuts, and other nuts) was assessed using data from a validated FFQ. The primary outcome was the change from baseline to 1 y in features of MetS [waist circumference (WC), glycemia, HDL cholesterol, triglyceride (TG), and systolic and diastolic blood pressure] and excess weight (body weight and BMI) according to tertiles of change in nut consumption. Secondary outcomes included changes in dietary and lifestyle characteristics. A generalized linear model was used to compare 1-y changes in features of MetS, weight, dietary intakes, and lifestyle characteristics across tertiles of change in nut consumption. RESULTS: As nut consumption increased, between each tertile there was a significant decrease in WC, TG, systolic blood pressure, weight, and BMI (P < 0.05), and a significant increase in HDL cholesterol (only in women, P = 0.044). The interaction effect between time and group was significant for total energy intake (P < 0.001), adherence to the Mediterranean diet (MedDiet) (P < 0.001), and nut consumption (P < 0.001). Across tertiles of increasing nut consumption there was a significant increase in extra virgin olive oil intake and adherence to the MedDiet; change in energy intake, on the other hand, was inversely related to consumption of nuts. CONCLUSIONS: Features of MetS and excess weight were inversely associated with nut consumption after a 1-y follow-up in the PREDIMED-Plus study cohort. This trial was registered at isrctn.com as ISRCTN89898870.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome Metabólico / Dieta / Sobrepeso / Nueces Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Nutr Año: 2020 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome Metabólico / Dieta / Sobrepeso / Nueces Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Nutr Año: 2020 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos